baber/WOPTO huggingface dataset:
Patent CA-2381183-A1 (CA)
Inventor: KISO OSAMU
IPC: E04F15/20
Filed: 2002-04-10
Abstract: The invention is to produce a sound-insulating floor structure which can conspicuously reduce heavy floor impact sounds.      The sound-insulating floor structure 1 includes a floor base 2 and an underfloor member 7. A plurality of sound-insulating floor members 5 are arranged between the floor base 2 and the underfloor member 7, and each of the sound-insulating floor members 5 includes a plurality of impact-absorbing members 3 and a support member 4 supporting the impact-absorbing members. The impact-absorbing members 3 are provided at at least one of upper and lower faces of the support member 4. Each of the sound-insulating floor members 5 is fixed to the floor base 2 or the underfloor member 7, thereby supporting the underfloor member 7.
Patent CA-2381313-A1 (CA)
Inventor: KELSO KAREN ANNE
IPC: A61L27/00
Filed: 2000-09-01
Abstract: L'invention concerne une matériau d'échantéité ou de revêtement biorésorbable destiné à une greffe prosthétique. Ce nouveau matériau d'étanchéité est réalisé à base de dextrane, obtenu de préférence par fermentation microbienne et croisé par réaction avec des formaldéhydes et de l'urée. Les produits de dégradation du matériau d'échantéité ou de revêtement présentent tous une masse moléculaire faible, et peuvent être aisément traités par l'organisme. L'invention concerne également un procédé de fabrication dudit nouveau matériau d'échantéité ou de revêtement.
Patent CA-2383812-A1 (CA)
Inventor: BASSON PETRUS
IPC: C22B3/02
Filed: 2000-09-05
Abstract: A method of recovering zinc from a zinc bearing sulphide mineral slurry which includes the steps of subjecting the slurry to a bioleaching process, supplying a feed gas which contains in excess of 21% oxygen by volume, to the slurry, and recovering zinc from a bioleach residue of the bioleaching process.
Patent CA-2388502-A1 (CA)
Title: All-organic corrosion inhibitor composition and uses thereof
Inventor: COLBY STEVEN J
IPC: C02F5/14
Filed: 2000-10-12
Abstract: This invention relates to an all-organic corrosion inhibiting composition comprising: (a) 6,6,6-(1,3,5-triazine-2,4,6-triyltriimino) tris hexanoic acid; and (b) a water-soluble phosphonated oligomer salt. The invention also relates to a process for inhibiting corrosion in a closed recirculating cooling water system.
Patent CA-2390960-A1 (CA)
Title: Improvements relating to activity surfaces
Inventor: MORTON PAUL
IPC: A63C19/02
Filed: 2000-09-29
Abstract: An apparatus for an a method of closing a fixed gap in an activity surface such as a turfed race-track is described. The apparatus comprises a movable turf tray having an upper surface with the same characteristics as the activity surface and means for guiding the tray into the gap so as to wedge the tray releasably in the gap and thereby to provide a substantially continuous activity surface. The apparatus can be used to provide a reconfigurable racetrack crossing with the permanent road gap in the racetrack being closeable by means of the movable turf tray. Overlapping edges of the turf tray provide a weight wedging action which provides reliable pressure joins. This also has application for creating reconfigurable turfed activity surfaces such as are used in sports stadia and the like.
Patent CA-2393179-A1 (CA)
Inventor: WITTER DAVID J
IPC: A61P13/12
Filed: 2000-12-01
Abstract: This invention pertains to compounds which specifically inhibit the adenosine A1, A2A, and A3 receptors and the use of these compounds to treat a disease associated with A1, A2A, and A3 adenosine receptors in a subject, comprising administering to the subject a therapeutically effective amount of the compounds.
Patent CA-2393942-A1 (CA)
Inventor: WANG POU-HSIUNG
IPC: A61K47/26
Filed: 2000-12-20
Abstract: A coating for masking or reducing the detectable presence of certain characteristic odor or odors, taste or tastes of pharmaceutical preparations , particularly valerian extracts, is described. The coating comprises from at least one to three coating compartments, in any combination or as a single- layer amalgam. The first coating compartment (4) preferably comprises a hydroxyalkyl cellulose and an anti-tackiness agent. The second coating compartment (6) preferably comprises a sugar and at least one anti-tackiness  agent. The third coating compartment (8) preferably comprises a methacrylate  copolymer, a hydroxyalkyl cellulose and an anti-tackiness agent. An option fourth coating compartment (10) may be applied as a cosmetic color coat, nee d not function as an odor-masking coat, and may be combined with one or more o f the other three coating compartments.
Patent CA-2394672-A1 (CA)
Inventor: DUNN RICHARD
IPC: A61L17/00
Filed: 2000-11-16
Abstract: A flowable composition containing a biocompatible, biodegradable, branched thermoplastic polymer is used to form solid matrices such as implants and controlled-release, drug-compositions in a body. The flowable composition with or without bioactive agent can be administered by syringe and needle to form in situ a solid matrix. Alternatively, the flowable composition can be used to for ex vivo solid biodegradable matrices such as articles, implants and devices. The articles implants and the like can then used as solid fasteners, prosthetic devices, and controlled drug compositions.
Patent CA-2397779-A1 (CA)
Title: Curable composition
Inventor: HASEGAWA NOBUHIRO
IPC: C08K3/26
Filed: 2000-12-22
Abstract: Many curable compositions comprising as a curing ingredient a vinyl polymer having at least one crosslinkable functional group contain general-purpose heavy calcium carbonate having a specific surface area of about 1 m2/g. Thes e compositions however have problems that it is difficult to obtain therefrom a cured object having a high elongation and that they are insufficient in adhesion to unprimed surfaces and in weathering adhesion. A curable composition which comprises (I) a vinyl polymer having at least one crosslinkable functional group and (II) heavy calcium carbonate having a specific surface area of 1.5 to 50 m2/g is improved in viscosity ratio and spatula cuttability, gives a cured object improved in breaking strength and elongation at break, and is improved in adhesion to various adherends and weathering adhesion.
Patent CA-2399561-A1 (CA)
Title: Recepteurs fc apparentes au cmh de classe i chez les ruminants
Inventor: HAMMARSTROM LENNART
IPC: C12N5/10
Filed: 2001-02-02
Abstract: L'invention concerne des molécules d'ADN à chaînes alpha du récepteur Fc (FcRn) transportant l'immunoglobuline G (IgG) chez le ruminant, notamment chez la vache, le dromadaire ou la chèvre (SEQ ID No. 1, SEQ ID No. 2, SEQ ID No. 3). Elle concerne également une protéine exprimée par lesdites molécules d'ADN à chaînes alpha du FcRn et comprenant les séquences SEQ ID No. 4, SEQ ID No. 5, SEQ ID No. 6. Elle concerne en outre des vecteurs contenant les molécules d'ADN à chaînes alpha du FcRn transportant l'IgG chez le ruminant, et des hôtes transformés avec ces vecteurs. Elle concerne enfin une méthode de production de colostrums ou de lait avec des niveaux accrus d'immunoglobuline ou de protéines fusionnées à des chaînes .gamma. d'immunoglobuline ou à des parties de l'immunoglobuline en interaction avec FcRn.
Patent CA-2400543-A1 (CA)
Title: The involvement of the bdnf gene in mood disorders
Inventor: MACCIARDI FABIO
IPC: C12Q1/68
Filed: 2002-08-30
Abstract: Methods and kits for determining susceptibility of a patient to mood disorders are described. The method involves analyzing a sample comprising nucleic acids from a patient for a polymorphism in the promoter region of the BDNF gene.
Patent CA-2401294-A1 (CA)
Title: An improved herbal composition having antiallergic properties and a process for the preparation thereof
Inventor: AGARWAL RAVINDRA KUMAR
IPC: A61P11/02
Filed: 2001-02-23
Abstract: The present invention relating to a herbal antiallergic composition which comprises a synergistic mixture of extracts from the fruits of Terminalia chebula, bark of A1bi=ia lebbeck, Terminalia bellerica and Emablica officinalis. The present invention also contains the fruits of Piper longum, Piper nigruni and of rhizomes of Zingiber officinale and thoroughly mixed to get the final composition which has potent antiallergic activity. The invention also relates to a process for the preparation of such composition.  The composition is particularly useful for the treatment of allergic conditions.
Patent CA-2401303-A1 (CA)
Inventor: BENYOVITS TED
IPC: B31B50/62
Filed: 2002-09-05
Abstract: The present invention is directed to an automated manufacturing line for production of boxlike structures and components therefor from laminated or solid flat material by V grooving, folding and gluing to form the boxlike structure or component. The automated line includes two or more machines selected from lineal V groovers, continuous cross V groovers, edge folding and gluing machines and multiple scoring machines. Each of the machines is provided with fences and feeders for automatically guiding the workpiece through the automated line. The positioning of fences, feeders, cutting heads and applicators of each of the machines is fully adjustable by providing drive means to position the fence, feeder, cutting head and applicator according to a predetermined position required for the production of a particular boxlike structure or component. The drive means is controled by a programmed controller having the parameters of the boxlike structure or component and having a means to cause the drive means to be activated to position the fence, feeder, cutting head or applicator in the correct position for the production of the desired boxlike structure or component.
Patent CA-2402667-A1 (CA)
Title: 6-oxygenated steroidal estrogens with aromatic a and b rings
Inventor: HILL EDWARD N
IPC: A61P5/30
Filed: 2001-03-09
Abstract: Novel estrogenic compounds of Formula (I) are provided, wherein the bond represented by the wavy line may be a single or double bond such that when the wavy line is a single bond, R1 is selected from the group consisting of hydrogen, sulfate and glucoronate or other esters, and when the wavy line is a double bond, R1 does not exist; R2 is lower alkyl; R3 may be selected from the group consisting of hydrogen, sulfate, or glucuronide or other esters; and R4 through R13 may independently be selected from the group consisting of hydrogen, hydroxy, ketone, lower alkyl, lower alkoxy, halogen, and carbonyl groups and R14 is selected from the group consisting of hydrogen, sulfate and glucoronide and other esters. When R1 is hydroxy, the hydroxy or ester substituent may have either an  alpha  or a  beta  orientation. Compositions of matter including compounds of the present invention are also provided as are methods of treating mammals in need of treatment using compounds of the present invention.
Patent CA-2402848-A1 (CA)
Inventor: FILA JOSEF ANTONIN
IPC: B64C3/26
Filed: 2001-04-05
Abstract: A method and apparatus of bonded wing construction in which skins (35, 39) having shaped protrusions (37, 41) are bonded to rib members having correspondingly shaped intrusions (33). The skins may also include differently shaped protrusions (53, 55) which are bonded to K-shaped spars (51) having correspondingly shaped intrusions (61, 63).
Patent CA-2404216-A1 (CA)
Title: Novel polypeptides, and nucleic acids encoding the same
Inventor: RASTELLI LUCA K
IPC: C07K16/18
Filed: 2001-03-22
Abstract: An isolated Wnt-1 related polypeptide comprising an amino acid sequence having at least 80% sequence identity to the sequence of SEQ ID NOS: 1, 3, 5, or 7 polynucleotides encoding these peptides,and antibodies to the polypeptides are useful in treating cancers
Patent CA-2404688-A1 (CA)
Title: Nuclear factor .kappa.b inducing factor
Inventor: DENEFLE PATRICE
IPC: C12N15/09
Filed: 2001-04-02
Abstract: The present invention is directed to nuclear factor kB (NFkB)-inducing facto r polypeptides (NFIF polypeptides) which are capable of inducing NKkB. The present invention includes within its scope NFIF polypeptides, including NFI F- 14b and NFIF-7a, DNA, including cDNA, encoding these polypeptides, and expression vectors capable of expressing NFIF polypeptides. Also included ar e methods and compositions for increasing NFkB induction in a patient, methods  and compositions for lowering NFkB induction in a patient, methods for inhibiting inflammation, and methods for manufacture of a medicament intende d for the treament and/or prevention of an NFkB-regulated inflammatory respons e. In addition, methods for determining whether a test compound inhibits or enhances the activity of NFIF polypeptides are provided.
Patent CA-2405132-A1 (CA)
Inventor: BROOKS GERALD
IPC: C07D277/20
Filed: 2001-03-29
Abstract: 2-(S)-hydroxymutilin carbamate derivatives of formula (I), in which R1 is a 5-or 6-membered optionally substituted heteroaryl group; and R2 is vinyl or ethyl, are useful in the treatment of bacterial infections.
Patent CA-2405626-A1 (CA)
Inventor: COOPER PHIL
IPC: B60N3/04
Filed: 2001-04-17
Abstract: A covering (10) defines a recess (22) of extent smaller than that of the covering, and a mat (32) having a shape and size conforming to those of said  recess. Preferably the covering is moulded to contour around a vehicle floor  and moulded to further form at least one of the recesses (22) in an upper surface of the covering.
Patent CA-2405726-A1 (CA)
Inventor: DINKLER CHARLES E
IPC: A61B19/00
Filed: 2001-04-06
Abstract: A surgical instrument support is provided having an articulated arm (28) wit h first structure (80) on a proximal end (22) of the arm. A lockable target ba ll (96) is rotatably mounted on a distal end (30) of the articulated arm, and t he lockable ball has a hole therein for receiving and supporting a surgical instrument. A mount (36) has second structure (76, 78) that receives and secures the proximal end of the articulated arm. The first structure on the articulated arm cooperates with the second structure on the mount to automatically align the proximal end of the articulated arm with the mount i n a repeatable relationship. The mount is adapted to be releasably attached to  a fixed structure (22). Thus, after establishing a desired alignment of the lockable ball to a patient, the articulated arm can be removed from the fixe d structure and then subsequently remounted therein without losing the desired  alignment of the lockable ball with the patient.
Patent CA-2407361-A1 (CA)
Title: Optical amplifying glass and optical waveguide
Inventor: OCHIAI KATSUHIRO
IPC: C03C3/253
Filed: 2002-10-07
Abstract: An optical amplifying glass comprising 100 parts by mass of a matrix glass and from 0.1 to 10 parts by mass of Er doped to the matrix glass, wherein the matrix glass comprises Bi2O3, at least one of B2O3 and SiO2, at least one member selected from the group consisting of Ga2O3, WO3 and TeO2, and La2O3 in such a ratio that Bi2O3 is from 20 to 80 mol%, B2O3+SiO2 is from 5 to 75 mol%, Ga2O3+WO3+TeO2 is from 0.1 to 35 mol%, and La2O3 is from 0.01 to 15 mol%.
Patent CA-2414165-A1 (CA)
Title: Operable latch
Inventor: GINGERICH NEWTON ROY
IPC: A01B59/00
Filed: 2002-12-13
Abstract: The self-engaging, solenoid-releasable with manual override, latch is designed for use in a variety of applications. As such, the latch accepts the striker peg of the load when misaligned, and the latch accommodates bouncing, sideways landing, etc of the load, without springing open.
Patent CA-2415003-A1 (CA)
Inventor: MAHOOD BRADLEY J
IPC: B65D5/462
Filed: 2002-12-19
Abstract: A promotional article for insertion into a carton containing beverage bottles.  The article comprises a premium attached to a tray-like member which is provided with means to engage and be borne by one, but preferably more, of the primary containers. The article is adapted to be contained within the carton without distorting any wall thereof. The invention also provides a promotional package comprising the article and beverage-filled bottles in a carton and a method of producing same.
Patent CA-2417061-A1 (CA)
Title: Badge and badge manufacturing device
Inventor: KANEO KENJI
IPC: A44B1/06
Filed: 2002-06-25
Abstract: The present invention relates to a badge where it is possible to select t he attachment position of attachment means such as a detachable pin while confirming orientation of a representation attached to a badge body, and a badge manufacturing device that is lightweight and robust, and that can be operated even at an unstable location and in a small space.  A badge 200 comprises a badge body 200a having a front cover 201, a she et body 213 mounted on a front surface plate 202 of the front cover 201, and a rear cover 205 for engaging with the front cover 201 to sandwich a peripheral edge of t he sheet body 213 between the rear cover peripheral edge 209 and the front cover peripheral edge 203, and mounting means 229, 237 for linking to the badge body 200a by selecting a direction to cross the rear surface plate 206 of the badge body 200a (X direction, Y direction or Z direction. A badge manufacturing device 1 comprises a base 2,  a sliding platform 100 provided on the base to be capable of reciprocating movement, first and second pressed molds 110 and 140 provided on both sides of the sliding platform 100 in the reciprocating directions, a pressing screw shaft 30 capable of moving in  the axial direction by screwing into a female screw section provided on a fixing membe r 20 fixed to the upper part of the base via struts 16 and 17, a pressing mold 40 provided on a lower end of the pressing screw shaft 30 for joining to the first pressed mo ld 110 or the second pressed mold 140, and an operating handle 32 provided on an upper par t of the pressing screw shaft 30
Patent CA-2417088-A1 (CA)
Title: Methods and molecules useful for identifying molecules that bind lfa-1 and for determining receptor occupancy
Inventor: KISHIMOTO TAKASHI
IPC: G01N33/50
Filed: 2001-08-13
Abstract: The present invention relates generally to a method for identifying molecule s that bind the R7.1 epitope of LFA-1 or bind LFA-1 such that the R7.1 epitope  is modified. The present invention further relates to a method for determini ng occupancy of the LFA-1 receptor by molecules that bind to the R7.1 epitope o r bind LFA-1 such that the R7.1 epitope is modified after administration to a subject. The present invention further relates to molecules useful in the methods of the invention.
Patent CA-2419414-A1 (CA)
Title: Use of triazinetrione sulfoxides for controlling coccidioses
Inventor: GREIF GISELA
IPC: A61P33/02
Filed: 2001-08-10
Abstract: The invention relates to the use of special derivatives of triazinetriones f or controlling coccidioses in animals, especially in pigs.
Patent CA-2420520-A1 (CA)
Inventor: SCHLAG PETER
IPC: D01D5/098
Filed: 2003-02-27
Abstract: Arrangement for the continuous production of a non-woven fibrous web made from aerodynamically stretched filaments of thermoplastic plastics using a spinneret and a cooling chamber, into which processing air for cooling the filaments can be introduced from the air supply chamber. Furthermore, the arrangement is provided with a stretching unit having a lower draft channel and a deposit unit for depositing the filaments for the non-woven fibrous web. The air supply chamber adjacent to the cooling chamber is divided into at least two chamber sections, from which processing air with various temperatures can be introduced.
Patent CA-2421765-A1 (CA)
Inventor: BRUXELLE DAVID
IPC: E21B43/08
Filed: 2001-09-25
Abstract: A well screen (10) comprising a wire (14) spirally wrapped around a perforated base pipe (12) and spacing the perforated base pipe from a woven wire mesh filtering medium (16).
Patent CA-2422272-A1 (CA)
Inventor: TENNYSON RODERICK C
IPC: G01K11/18
Filed: 2003-03-14
Abstract: Brillouin scattering spectrum analysis is used to measure strain, displacement, temperature or other physical quantities at any location along an optical fiber attached to a structure. The fiber can be interrogated with different pulse widths for coarse and fine scans. The fiber can also have multiple sensors, either formed in a single fiber or branching off from a backbone fiber, in which case other segments of the fiber can be used for temperature compensation.
Patent CA-2422984-A1 (CA)
Inventor: AUGER CLAUDE
IPC: A01G23/097
Filed: 2003-03-20
Abstract: A method and an apparatus for reducing damage caused to a circular saw blade on a delimbing machine. A step involves mounting at least one contact member to an inside surface of an access door of a saw head compartment. The at least one contact member is positioned immediately adjacent to and spaced radially inwardly from a lower circumferential peripheral edge of the circular saw blade when in a retracted position within the saw head compartment. Lateral movement of the lower circumferential peripheral edge of the circular saw blade is confined by the at least one contact member engaging a first face of the circular saw blade along the lower circumferential peripheral edge.
Patent CA-2423695-A1 (CA)
Title: Segmenting electronic documents for use on a device of limited capability
Inventor: BERGER ADAM L
IPC: G06F40/00
Filed: 2001-09-27
Abstract: A method includes receiving a machine readable file containing a document (12) that is to be served to a client (10) for display on a client device (10), the organization of each of the document (12) in the file being expressed as a hierarchy of information, and deriving subdocuments (1) from the hierarchy of the information, each of the subdocuments (1) being expressed in a format that permits it to be served separately to the client using a hypertext transmission protocol, at least one of the subdocuments (1) containing information that enables it to be linked to another one of the subdocuments (1).
Patent CA-2426849-A1 (CA)
Inventor: TSUKADA OSAMU
IPC: A61F2/958
Filed: 2001-09-07
Abstract: A catheter for treatment of prostatic hypertrophy (100), comprising a catheter body (1) having a perfusion passage (11), a first fluid passage (13), a second fluid passage (14), and a urination passage (15), a branch member (2) formed integrally with the base part of the catheter body (1) and having fluid filling and extracting ports allowed to communicate with passages, a first balloon (3) for remaining in urinary bladder installed at the end part of the catheter body (1) and allowed to communicate with the first fluid passage (13), a second balloon (4) for pressing prostata provided at the end part of the catheter body (1) and on the upstream side of the first balloon (3) and allowed to communicate with the second fluid passage (14), and a tip stopper (5) installed at the tip of the catheter body (1).
Patent CA-2436231-A1 (CA)
Inventor: TREMAYNE TERRENCE COLIN
IPC: A63B21/16
Filed: 2002-01-18
Abstract: L'invention concerne un dispositif d'exercice physique, comprenant des moyens (40, 41, 42, 43) pour le monter sur un siège (100), un moyen de résistance variable (30) fixé sur les moyens de montage (40, 41, 42, 43), une poignée (10) fixée à une première extrémité du moyen de résistance (30) et un deuxième moyen de manoeuvre (20) fixé sur l'extrémité opposée du moyen de résistance (30). Un mouvement de la poignée (10), du deuxième moyen de manoeuvre (20) ou des deux permet de s'exercer physiquement contre la force du moyen de résistance (30). Ce moyen de résistance (30) comporte de préférence un élément souple, sous forme d'un cordon élastique (39) ou d'un ressort disposé à l'intérieur d'une enveloppe.
Patent CA-2437864-A1 (CA)
Inventor: FUCHS HENRY
IPC: A61P31/04
Filed: 2002-02-12
Abstract: L'invention concerne des procédés permettant de prévenir des infections respiratoires associées à l'intubation et/ou à la ventilation mécanique, telles que la pneumonie associée à la ventilation, chez des patients intubés. Le procédé consiste de manière générale à administrer par voie topique une composition comprenant un peptide IB-367 dans la cavité buccale d'un patient intubé. Les peptides IB 367 induisant très peu de résistance, un des avantages majeurs de l'invention réside dans le fait que la thérapie prophylactique peut être appliquée sans souci de créer des souches de pathogènes résistants.